Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Estradiol Transdermal Patches Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 25 mg/day
  • 1.3.3 50 mg/day
  • 1.3.4 75 mg/day
  • 1.3.5 100 mg/day
• 1.4 Market Segment by Application
  • 1.4.1 Global Estradiol Transdermal Patches Market Share by Application (2019-2025)
  • 1.4.2 Male
  • 1.4.3 Female
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Estradiol Transdermal Patches Market Size
  • 2.1.1 Global Estradiol Transdermal Patches Revenue 2014-2025
  • 2.1.2 Global Estradiol Transdermal Patches Sales 2014-2025
• 2.2 Estradiol Transdermal Patches Growth Rate by Regions
  • 2.2.1 Global Estradiol Transdermal Patches Sales by Regions 2014-2019
  • 2.2.2 Global Estradiol Transdermal Patches Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Estradiol Transdermal Patches Sales by Manufacturers
  • 3.1.1 Estradiol Transdermal Patches Sales by Manufacturers 2014-2019
  • 3.1.2 Estradiol Transdermal Patches Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Estradiol Transdermal Patches Revenue by Manufacturers (2014-2019)
  • 3.2.2 Estradiol Transdermal Patches Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Estradiol Transdermal Patches Market Concentration Ratio (CR5 and HHI)
• 3.3 Estradiol Transdermal Patches Price by Manufacturers
• 3.4 Key Manufacturers Estradiol Transdermal Patches Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Estradiol Transdermal Patches Market
• 3.6 Key Manufacturers Estradiol Transdermal Patches Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 25 mg/day Sales and Revenue (2014-2019)
  • 4.1.2 50 mg/day Sales and Revenue (2014-2019)
  • 4.1.3 75 mg/day Sales and Revenue (2014-2019)
  • 4.1.4 100 mg/day Sales and Revenue (2014-2019)
• 4.2 Global Estradiol Transdermal Patches Sales Market Share by Type
• 4.3 Global Estradiol Transdermal Patches Revenue Market Share by Type
• 4.4 Estradiol Transdermal Patches Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Estradiol Transdermal Patches Sales by Application

6 United States

• 6.1 United States Estradiol Transdermal Patches Breakdown Data by Company
• 6.2 United States Estradiol Transdermal Patches Breakdown Data by Type
• 6.3 United States Estradiol Transdermal Patches Breakdown Data by Application

7 European Union

• 7.1 European Union Estradiol Transdermal Patches Breakdown Data by Company
• 7.2 European Union Estradiol Transdermal Patches Breakdown Data by Type
• 7.3 European Union Estradiol Transdermal Patches Breakdown Data by Application

8 China

• 8.1 China Estradiol Transdermal Patches Breakdown Data by Company
• 8.2 China Estradiol Transdermal Patches Breakdown Data by Type
• 8.3 China Estradiol Transdermal Patches Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Estradiol Transdermal Patches Breakdown Data by Company
• 9.2 Rest of World Estradiol Transdermal Patches Breakdown Data by Type
• 9.3 Rest of World Estradiol Transdermal Patches Breakdown Data by Application
• 9.4 Rest of World Estradiol Transdermal Patches Breakdown Data by Countries
  • 9.4.1 Rest of World Estradiol Transdermal Patches Sales by Countries
  • 9.4.2 Rest of World Estradiol Transdermal Patches Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Novartis
  • 10.1.1 Novartis Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Estradiol Transdermal Patches
  • 10.1.4 Estradiol Transdermal Patches Product Introduction
  • 10.1.5 Novartis Recent Development
• 10.2 Bayer Healthcare Pharmaceuticals
  • 10.2.1 Bayer Healthcare Pharmaceuticals Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Estradiol Transdermal Patches
  • 10.2.4 Estradiol Transdermal Patches Product Introduction
  • 10.2.5 Bayer Healthcare Pharmaceuticals Recent Development
• 10.3 Watson Labs
  • 10.3.1 Watson Labs Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Estradiol Transdermal Patches
  • 10.3.4 Estradiol Transdermal Patches Product Introduction
  • 10.3.5 Watson Labs Recent Development
• 10.4 Women First Healthcare Inc
  • 10.4.1 Women First Healthcare Inc Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Estradiol Transdermal Patches
  • 10.4.4 Estradiol Transdermal Patches Product Introduction
  • 10.4.5 Women First Healthcare Inc Recent Development
• 10.5 Noven
  • 10.5.1 Noven Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Estradiol Transdermal Patches
  • 10.5.4 Estradiol Transdermal Patches Product Introduction
  • 10.5.5 Noven Recent Development
• 10.6 AbbVie
  • 10.6.1 AbbVie Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Estradiol Transdermal Patches
  • 10.6.4 Estradiol Transdermal Patches Product Introduction
  • 10.6.5 AbbVie Recent Development
• 10.7 Lumara Health
  • 10.7.1 Lumara Health Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Estradiol Transdermal Patches
  • 10.7.4 Estradiol Transdermal Patches Product Introduction
  • 10.7.5 Lumara Health Recent Development
• 10.8 ANI Pharmaceuticals
  • 10.8.1 ANI Pharmaceuticals Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Estradiol Transdermal Patches
  • 10.8.4 Estradiol Transdermal Patches Product Introduction
  • 10.8.5 ANI Pharmaceuticals Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Estradiol Transdermal Patches Sales Channels
  • 11.2.2 Estradiol Transdermal Patches Distributors
• 11.3 Estradiol Transdermal Patches Customers

12 Market Forecast

• 12.1 Global Estradiol Transdermal Patches Sales and Revenue Forecast 2019-2025
• 12.2 Global Estradiol Transdermal Patches Sales Forecast by Type
• 12.3 Global Estradiol Transdermal Patches Sales Forecast by Application
• 12.4 Estradiol Transdermal Patches Forecast by Regions
  • 12.4.1 Global Estradiol Transdermal Patches Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Estradiol Transdermal Patches Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Estradiol Transdermal Patches is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Estradiol Transdermal Patches.

This report studies the global market size of Estradiol Transdermal Patches, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Estradiol Transdermal Patches sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novartis
Bayer Healthcare Pharmaceuticals
Watson Labs
Women First Healthcare Inc
Noven
AbbVie
Lumara Health
ANI Pharmaceuticals

Market Segment by Product Type
25 mg/day
50 mg/day
75 mg/day
100 mg/day

Market Segment by Application
Male
Female

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Estradiol Transdermal Patches status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Estradiol Transdermal Patches manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Estradiol Transdermal Patches are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025